These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2987720

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ, Morgan WW.
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The response of rat brain protein synthesis to ethanol and sodium barbital.
    Tewari S, Greenberg SA, Do K, Grey PA.
    Alcohol Drug Res; 1987 Sep; 7(4):243-58. PubMed ID: 3828001
    [Abstract] [Full Text] [Related]

  • 7. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR, Okamoto M.
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [Abstract] [Full Text] [Related]

  • 8. Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence.
    Siew C, Goldstein DB.
    J Pharmacol Exp Ther; 1978 Mar; 204(3):541-6. PubMed ID: 564954
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR, Okamoto M.
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [Abstract] [Full Text] [Related]

  • 11. Alterations in brain cyclic guanosine 3':5'-monophosphate levels after acute and chronic treatment with ethanol.
    Hunt WA, Redos JD, Dalton TK, Catravas GN.
    J Pharmacol Exp Ther; 1977 Apr; 201(1):103-9. PubMed ID: 15100
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of alcohol and barbital physical dependence in mice.
    Kaneto H, Kaneda H, Kawatani S.
    Yakubutsu Seishin Kodo; 1987 Jun; 7(2):327-32. PubMed ID: 3687245
    [Abstract] [Full Text] [Related]

  • 16. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M, Hinman DJ, Aaronson LM.
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [Abstract] [Full Text] [Related]

  • 17. Depression of cerebellar cGMP by barbiturates. Relationship to locomotor activity.
    Morgan WW, Pfeil KA.
    Neuropharmacology; 1984 Jul; 23(7A):773-7. PubMed ID: 6089023
    [Abstract] [Full Text] [Related]

  • 18. Physical dependence capacity of brotizolam in rhesus monkeys. 2nd communication: primary dependence and barbital substitution.
    Stockhaus K.
    Arzneimittelforschung; 1986 Mar; 36(3A):601-5. PubMed ID: 3718584
    [Abstract] [Full Text] [Related]

  • 19. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G.
    Psychopharmacology (Berl); 1978 Oct 31; 59(2):123-8. PubMed ID: 103112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.